The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N05 | Psycholeptics | |
3 | N05A | Antipsychotics | |
4 | N05AL | Benzamides |
Code | Title | |
---|---|---|
N05AL01 | Sulpiride | |
N05AL02 | Sultopride | |
N05AL03 | Tiapride | |
N05AL04 | Remoxipride | |
N05AL05 | Amisulpride | |
N05AL06 | Veralipride | |
N05AL07 | Levosulpiride |
Active Ingredient | Description | |
---|---|---|
Amisulpride |
Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes. |
|
Levosulpiride |
Levosulpiride is a selective antagonist at dopamine (D) receptors. Levosulpiride exerts a regulation action both on the central and peripheral nervous circuits controlling the dynamics of digestive system. |
|
Nemonapride |
|
|
Sulpiride |
Sulpiride is a member of the group of substituted benzamides, which are structurally distinct from the phenothiazines, butyrophenones and thioxanthenes. One of the characteristics of sulpiride is its bimodal activity, as it has both antidepressant and neuroleptic properties. Schizophrenia characterised by a lack of social contact can benefit strikingly. |
|
Sultopride |
|
|
Tiapride |
Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). |
Title | Information Source | Document Type | |
---|---|---|---|
DEVODIL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
DISLEP Solution for injection / infusion | Medicines Authority (MT) | MPI, EU: SmPC | |
ESPIRIDE Capsule | Health Products Regulatory Authority (ZA) | MPI, Generic | |
SOLIAN Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SULPIREN Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
SULVORID Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |